Charcot Neuroarthropathy
Charcot’s Arthropathy — The Neuropathic Joint
From Jean-Martin Charcot’s 1868 tabetic series to the modern diabetic-foot epidemic — eight integrating clinical modules.
Why a course on Charcot foot?
Charcot neuroarthropathy (CN) is a destructive, non-infectious arthropathy of weight-bearing joints that occurs in patients with peripheral sensory neuropathy. It is the most disabling musculoskeletal complication of diabetes mellitus — ~85% of modern cases occur in diabetics— and yet it is underdiagnosed in primary care, where the swollen, warm foot of early Stage 0 Charcot is reliably mistaken for cellulitis or DVT.
The cost of getting it wrong is high. A missed diagnosis allows weight-bearing on an unstable, fragmenting foot; the result is the rocker-bottom deformity, plantar ulceration, secondary osteomyelitis, and ultimately major amputation. The 5-year mortality after diabetic foot amputation exceeds that of breast, prostate, and colorectal cancer (Armstrong, Boulton & Bus, NEJM 2017). Every clinician who sees diabetic feet — primary care, endocrinology, vascular, podiatric, orthopaedic — must recognise CN early and offload it absolutely. This course traces the biology, the imaging, the staging system that drives treatment, and the surgical reconstructive options when conservative care fails. It cross-references Cell Physiology and Pharmacology.
Course Parts
Overview & Epidemiology
A destructive arthropathy of weight-bearing joints in patients with sensory neuropathy. Charcot 1868 (tabes dorsalis), the modern diabetic-foot crisis: ~85% of cases, 0.1–7% prevalence in diabetics.
Pathophysiology
Neurotrophic and neurovascular theories reconciled. Autonomic dysregulation, hyperaemia, RANK-L driven osteolysis, repetitive microtrauma, and the inflammatory amplification loop.
The Diabetic Foot
Loss of protective sensation as the prerequisite. Semmes-Weinstein 5.07 monofilament, peak plantar pressures, the IWGDF risk-stratification system, and integration with peripheral arterial disease.
Imaging
Plain radiographs (often normal at Stage 0). MRI as the gold standard for early Charcot vs. osteomyelitis. CT for surgical planning. Nuclear medicine: Tc-MDP, In-WBC, FDG-PET.
Eichenholtz Staging
Stage 0 (pre-radiographic), I (development — hyperaemia, fragmentation), II (coalescence), III (consolidation, residual deformity). The Brodsky / Sanders anatomic classifications.
Conservative Management
Total contact casting (TCC) as the standard of care: 8–12 weeks of strict offloading. CROW boot for transition. Bisphosphonates (controversial). The offloading principle.
Surgical Management
Indications: deformity, ulceration, instability. Exostectomy, midfoot/hindfoot arthrodesis, internal vs external (Ilizarov) fixation, the super-construct principle.
Prevention & Prognosis
Glycemic control, the annual diabetic foot exam, patient education, prosthetics. Long-term ulceration and amputation risk; mortality at 5 years approaching that of common cancers.
What you’ll learn
- Recognise the warm, swollen, deformity-prone foot of Stage 0 Charcot.
- Reconcile the neurotrophic and neurovascular theories with RANK-L osteolysis.
- Use the Semmes-Weinstein 5.07 monofilament to define loss of protective sensation.
- Distinguish Charcot from osteomyelitis on MRI (joint vs. bone-centred oedema).
- Apply Eichenholtz Stages 0–III to drive cast-vs-CROW-vs-surgery decisions.
- Run total contact casting as the gold-standard offloading technique.
- Reason about midfoot arthrodesis using the super-construct principles.
- Counsel a high-risk patient on lifelong foot screening and footwear.
Prerequisites
Working knowledge of bone biology (RANK / RANK-L / OPG), basic peripheral-nerve anatomy, and the diabetic complications spectrum. The course cross-references Cell Physiology and Pharmacology. Readers familiar with the broader diabetic-foot literature (IWGDF, ADA, Wound Healing Society) will find the staging and surgical sections faster going.